GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ebov glycoprotein with modified HR1C and HR2 stalk at 3.2 a resolution

Analyse Crystal structure of ebov glycoprotein with modified HR1C and HR2 stalk at 3.2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7JPH
Type
protein
Length
398 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Envelope glycoprotein
UniProt
Q05320
Ligands
NAG, MAN, BMA, PO4
Pockets
7 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 21% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnvelope glycoproteinprotein26211% helix, 33% strand—
BEnvelope glycoproteinprotein13639% helix, 11% strandQ05320

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 3 copies · chains A
  • BMA · beta-D-mannopyranose · sugar
  • PO4 · Phosphate ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11780.610.8326empty
22490.540.7731empty
31120.510.8119PO4
41230.450.7720empty
51160.400.7516empty

Interfaces

1 interface between chains.

  • A–B · 2909 Ų buried · 33 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 7JPH · Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.